Kingsley Lawrence D

SEC source: 0001209191-19-023449 · doc4.xml · nonDerivative · entry 1

Kingsley Lawrence D · CIK 0001301427 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,101.62

F1 · balance_after: The reported transaction involved the crediting of 282.61 Common Stock Equivalents (CSEs), each of which may be settled in one share of common stock, to the reporting person's account under the Company's Deferred Compensation Plan for Directors (DC Plan) in connection with the reporting person's election to defer receipt of the reporting person's quarterly cash retainer payment. The total reported in column 5 includes the 282.61 newly acquired CSEs, and 54.22 CSEs and deferred stock units acquired pursuant to the dividend reinvestment feature of the DC Plan.

SEC source: 0001246360-19-000453 · form.xml · nonDerivative · entry 1

Kingsley Lawrence D · CIK 0001301427 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,785.868

F1 · shares: Shares delivered as compensation for service as a director under the 2003 Directors Stock Plan.

SEC source: 0001567619-19-002652 · doc1.xml · nonDerivative · entry 1

Kingsley Lawrence D · CIK 0001301427 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,403

F1 · price: Represents the weighted average price of the shares purchased ranging from a low of $208.55 to a high of $208.88 per share. The undersigned undertakes, upon request by the Commission staff, the Issuer or a security holder of the Issuer, to provide full information regarding the number of shares purchased at each separate price.

SEC source: 0001567619-19-002178 · doc1.xml · nonDerivative · entry 1

Kingsley Lawrence D · CIK 0001301427 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,998

F1 · shares: Represents deferred stock units acquired pursuant to the IDEXX Laboratories, Inc. Director Deferred Compensation Plan (the "Plan") in accordance with Rule 16b-3. The number of deferred stock units, rounded up or down to the nearest whole unit, is determined by dividing the amount of cash compensation deferred pursuant to the Plan ($25,000.00) by the closing price of IDEXX Laboratories, Inc. common stock on the date of the deferral, or if no such price is reported for that date, the closing price for the next preceding date for which such price was reported. Each deferred stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock. The deferred stock units vest immediately upon grant and are payable only as common stock one year following the Director's resignation from the Board of Directors or on such other nondiscretionary and objectively determinable date(s) selected in accordance with the terms of the Plan.

SEC source: 0001209191-19-002159 · doc4.xml · nonDerivative · entry 1

Kingsley Lawrence D · CIK 0001301427 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,764.8

F1 · balance_after: The reported transaction involved the crediting of 312.22 Common Stock Equivalents (CSEs), each of which may be settled in one share of common stock, to the reporting person's account under the Company's Deferred Compensation Plan for Directors (DC Plan) in connection with the reporting person's election to defer receipt of the reporting person's quarterly cash retainer payment. The total reported in column 5 includes the 312.22 newly acquired CSEs, and 56.17 CSEs and deferred stock units acquired pursuant to the dividend reinvestment feature of the DC Plan.

SEC source: 0001567619-18-004942 · doc1.xml · nonDerivative · entry 1

Kingsley Lawrence D · CIK 0001301427 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,878

F1 · shares: Represents deferred stock units acquired pursuant to the IDEXX Laboratories, Inc. Director Deferred Compensation Plan (the "Plan") in accordance with Rule 16b-3. The number of deferred stock units, rounded up or down to the nearest whole unit, is determined by dividing the amount of cash compensation deferred pursuant to the Plan ($25,000.00) by the closing price of IDEXX Laboratories, Inc. common stock on the date of the deferral, or if no such price is reported for that date, the closing price for the next preceding date for which such price was reported. Each deferred stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock. The deferred stock units vest immediately upon grant and are payable only as common stock one year following the Director's resignation from the Board of Directors or on such other nondiscretionary and objectively determinable date(s) selected in accordance with the terms of the Plan.

SEC source: 0001246360-18-002278 · form.xml · derivative · entry 1

Kingsley Lawrence D · CIK 0001301427 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,559

Underlying: Common Stock · 657 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Rockwell Automation common stock.

F2 · shares: Restricted stock units delivered as compensation for service as a director under the 2003 Directors Stock Plan.

F3 · derivative.exercise_date: Payable upon retirement, change of control and certain other circumstances.

F3 · derivative.expiration_date: Payable upon retirement, change of control and certain other circumstances.

SEC source: 0001209191-18-054055 · doc4.xml · nonDerivative · entry 1

Kingsley Lawrence D · CIK 0001301427 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,396.41

F1 · balance_after: The reported transaction involved the crediting of 242.54 Common Stock Equivalents (CSEs), each of which may be settled in one share of common stock, to the reporting person's account under the Company's Deferred Compensation Plan for Directors (DC Plan) in connection with the reporting person's election to defer receipt of the reporting person's quarterly cash retainer payment. The total reported in column 5 includes the 242.54 newly acquired CSEs, and 38.78 CSEs and deferred stock units acquired pursuant to the dividend reinvestment feature of the DC Plan.

SEC source: 0001140361-18-034855 · doc1.xml · nonDerivative · entry 1

Kingsley Lawrence D · CIK 0001301427 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,759

F1 · shares: Represents deferred stock units acquired pursuant to the IDEXX Laboratories, Inc. Director Deferred Compensation Plan (the "Plan") in accordance with Rule 16b-3. The number of deferred stock units, rounded up or down to the nearest whole unit, is determined by dividing the amount of cash compensation deferred pursuant to the Plan ($25,000.00) by the closing price of IDEXX Laboratories, Inc. common stock on the date of the deferral, or if no such price is reported for that date, the closing price for the next preceding date for which such price was reported. Each deferred stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock. The deferred stock units vest immediately upon grant and are payable only as common stock one year following the Director's resignation from the Board of Directors or on such other nondiscretionary and objectively determinable date(s) selected in accordance with the terms of the Plan.

SEC source: 0001209191-18-044574 · doc4.xml · nonDerivative · entry 1

Kingsley Lawrence D · CIK 0001301427 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,115.09

SEC source: 0001246360-18-001804 · form.xml · derivative · entry 1

Kingsley Lawrence D · CIK 0001301427 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,902

Underlying: Common Stock · 164 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Rockwell Automation common stock.

F2 · shares: Restricted stock units delivered as compensation for service as a director under the 2003 Directors Stock Plan.

F3 · derivative.exercise_date: Payable upon retirement, change of control and certain other circumstances.

F3 · derivative.expiration_date: Payable upon retirement, change of control and certain other circumstances.

SEC source: 0001209191-18-040943 · doc4.xml · nonDerivative · entry 1

Kingsley Lawrence D · CIK 0001301427 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,115.09

F1 · balance_after: The reported transaction involved the crediting of 197.35 Common Stock Equivalents (CSEs), each of which may be settled in one share of common stock, to the reporting person's account under the Company's Deferred Compensation Plan for Directors (DC Plan) in connection with the reporting person's election to defer receipt of the reporting person's quarterly cash retainer payment. The total reported in column 5 includes the 197.35 newly acquired CSEs, and 31.29 CSEs and deferred stock units acquired pursuant to the dividend reinvestment feature of the DC Plan.

SEC source: 0001140361-18-023102 · doc1.xml · derivative · entry 2

Kingsley Lawrence D · CIK 0001301427 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,187

Underlying: Common Stock · 2,187 shares

Expires 2028-05-08

F3 · price: Not applicable.

F2 · derivative.exercise_date: Grant of option to buy shares of IDEXX Laboratories, Inc. common stock that vest in one installment on May 9, 2019.

SEC source: 0001140361-18-023102 · doc1.xml · derivative · entry 1

Kingsley Lawrence D · CIK 0001301427 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 720

Underlying: Common Stock · 224 shares

Expires not disclosed

F1 · derivative.exercise_price: Each deferred stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock. Deferred stock units vest in one installment on the one year anniversary of the date of grant or on the date of the 2019 annual meeting of shareholders, whichever event is earlier, and are payable as common stock one year following the Director's resignation from the Board of Directors.

F3 · price: Not applicable.

F1 · derivative.exercise_date: Each deferred stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock. Deferred stock units vest in one installment on the one year anniversary of the date of grant or on the date of the 2019 annual meeting of shareholders, whichever event is earlier, and are payable as common stock one year following the Director's resignation from the Board of Directors.

F1 · derivative.expiration_date: Each deferred stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock. Deferred stock units vest in one installment on the one year anniversary of the date of grant or on the date of the 2019 annual meeting of shareholders, whichever event is earlier, and are payable as common stock one year following the Director's resignation from the Board of Directors.

SEC source: 0001140361-18-021320 · doc1.xml · nonDerivative · entry 1

Kingsley Lawrence D · CIK 0001301427 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,654

F1 · shares: Represents deferred stock units acquired pursuant to the IDEXX Laboratories, Inc. Director Deferred Compensation Plan (the "Plan") in accordance with Rule 16b-3. The number of deferred stock units, rounded up or down to the nearest whole unit, is determined by dividing the amount of cash compensation deferred pursuant to the Plan ($18,750.00) by the closing price of IDEXX Laboratories, Inc. common stock on the date of the deferral, or if no such price is reported for that date, the closing price for the next preceding date for which such price was reported. Each deferred stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock. The deferred stock units vest immediately upon grant and are payable only as common stock one year following the Director's resignation from the Board of Directors or on such other nondiscretionary and objectively determinable date(s) selected in accordance with the terms of the Plan.

SEC source: 0001209191-18-026529 · doc4.xml · nonDerivative · entry 1

Kingsley Lawrence D · CIK 0001301427 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,886.46

F1 · balance_after: The reported transaction involved the crediting of 1,237 deferred stock units granted under the Polaris Industries Inc. 2017 Omnibus Incentive Plan, each of which may be settled in one share of common stock pursuant to the Company's Deferred Compensation Plan for Directors.

SEC source: 0001246360-18-001230 · form.xml · derivative · entry 1

Kingsley Lawrence D · CIK 0001301427 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,738

Underlying: Common Stock · 163 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Rockwell Automation common stock.

F2 · shares: Restricted stock units delivered as compensation for service as a director under the 2003 Directors Stock Plan.

F3 · derivative.exercise_date: Payable upon retirement, change of control and certain other circumstances.

F3 · derivative.expiration_date: Payable upon retirement, change of control and certain other circumstances.

SEC source: 0001209191-18-023876 · doc4.xml · nonDerivative · entry 1

Kingsley Lawrence D · CIK 0001301427 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,649.46

F1 · balance_after: The reported transaction involved the crediting of 216.07 Common Stock Equivalents (CSEs), each of which may be settled in one share of common stock, to the reporting person's account under the Company's Deferred Compensation Plan for Directors (DC Plan) in connection with the reporting person's election to defer receipt of the reporting person's quarterly cash retainer payment. The total reported in column 5 includes the 216.07 newly acquired CSEs and 27.16 CSEs and DSUs acquired pursuant to the dividend reinvestment feature of the DC Plan.

SEC source: 0001140361-18-008858 · doc1.xml · nonDerivative · entry 1

Kingsley Lawrence D · CIK 0001301427 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,558

SEC source: 0001246360-18-000507 · form.xml · derivative · entry 1

Kingsley Lawrence D · CIK 0001301427 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,575

Underlying: Common Stock · 213 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Rockwell Automation common stock.

F2 · shares: Restricted stock units delivered as compensation for service as a director under the 2003 Directors Stock Plan.

F3 · derivative.exercise_date: Payable upon retirement, change of control and certain other circumstances.

F3 · derivative.expiration_date: Payable upon retirement, change of control and certain other circumstances.

SEC source: 0001140361-18-004512 · doc1.xml · nonDerivative · entry 1

Kingsley Lawrence D · CIK 0001301427 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,558

F1 · shares: Represents deferred stock units acquired pursuant to the IDEXX Laboratories, Inc. Director Deferred Compensation Plan (the "Plan") in accordance with Rule 16b-3. The number of deferred stock units, rounded up or down to the nearest whole unit, is determined by dividing the amount of cash compensation deferred pursuant to the Plan ($18,659.00) by the closing price of IDEXX Laboratories, Inc. common stock on the date of the deferral, or if no such price is reported for that date, the closing price for the next preceding date for which such price was reported. Each deferred stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock. The deferred stock units vest immediately upon grant and are payable only as common stock one year following the Director's resignation from the Board of Directors or on such other nondiscretionary and objectively determinable date(s) selected in accordance with the terms of the Plan.

SEC source: 0001246360-18-000008 · form.xml · derivative · entry 1

Kingsley Lawrence D · CIK 0001301427 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,362

Underlying: Common Stock · 143 shares

Expires not disclosed

F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Rockwell Automation common stock.

F2 · shares: Restricted stock units delivered as compensation for service as a director under the 2003 Directors Stock Plan.

F3 · derivative.exercise_date: Payable upon retirement, change of control and certain other circumstances.

F3 · derivative.expiration_date: Payable upon retirement, change of control and certain other circumstances.

SEC source: 0001209191-18-001859 · doc4.xml · nonDerivative · entry 1

Kingsley Lawrence D · CIK 0001301427 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,406.23

F1 · balance_after: The reported transaction involved the crediting of 193.08 Common Stock Equivalents (CSEs), each of which may be settled in one share of common stock, to the reporting person's account under the Company's Deferred Compensation Plan for Directors (DC Plan) in connection with the reporting person's election to defer receipt of the reporting person's quarterly cash retainer payment. The total reported in column 5 includes the 193.08 newly acquired CSEs and 23.71 CSEs and DSUs acquired pursuant to the dividend reinvestment feature of the DC Plan.

SEC source: 0001140361-17-040575 · doc1.xml · nonDerivative · entry 1

Kingsley Lawrence D · CIK 0001301427 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,458

F1 · shares: Represents deferred stock units acquired pursuant to the IDEXX Laboratories, Inc. Director Deferred Compensation Plan (the "Plan") in accordance with Rule 16b-3. The number of deferred stock units, rounded up or down to the nearest whole unit, is determined by dividing the amount of cash compensation deferred pursuant to the Plan ($18,750.00) by the closing price of IDEXX Laboratories, Inc. common stock on the date of the deferral, or if no such price is reported for that date, the closing price for the next preceding date for which such price was reported. Each deferred stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock. The deferred stock units vest immediately upon grant and are payable only as common stock one year following the Director's resignation from the Board of Directors or on such other nondiscretionary and objectively determinable date(s) selected in accordance with the terms of the Plan.

SEC source: 0001246360-17-002836 · form.xml · nonDerivative · entry 1

Kingsley Lawrence D · CIK 0001301427 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,550.868

F1 · shares: Shares delivered as compensation for service as a director under the 2003 Directors Stock Plan.

SEC source: 0001209191-17-055998 · doc4.xml · nonDerivative · entry 1

Kingsley Lawrence D · CIK 0001301427 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,039.44

F1 · balance_after: The reported transaction involved the crediting of 229.74 Common Stock Equivalents (CSEs), each of which may be settled in one share of common stock, to the reporting person's account under the Company's Deferred Compensation Plan for Directors (DC Plan) in connection with the reporting person's election to defer receipt of the reporting person's quarterly cash retainer payment. The reporting person has reported prior awards of CSEs, as well as prior awards of Deferred Stock Units (DSUs, which are also settled in shares of common stock on a 1 for 1 basis) under the Company's Omnibus Incentive Plan, in Table II of Form 4. The total reported in column 5 includes the 229.74 newly acquired CSEs, 45.64 CSEs and DSUs acquired pursuant to the dividend reinvestment feature of the DC Plan, 4,839.06 of previously reported CSEs and DSUs, and 6,925 of previously reported shares of Company common stock.

SEC source: 0001140361-17-030282 · doc1.xml · nonDerivative · entry 1

Kingsley Lawrence D · CIK 0001301427 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,344

F1 · price: Represents the weighted average sales price of the shares sold ranging from a low of $151.73 to a high of $151.76 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.

SEC source: 0001140361-17-029428 · doc1.xml · nonDerivative · entry 1

Kingsley Lawrence D · CIK 0001301427 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,344

F1 · shares: Represents deferred stock units acquired pursuant to the IDEXX Laboratories, Inc. Director Deferred Compensation Plan (the "Plan") in accordance with Rule 16b-3. The number of deferred stock units, rounded up or down to the nearest whole unit, is determined by dividing the amount of cash compensation deferred pursuant to the Plan ($18,750.00) by the closing price of IDEXX Laboratories, Inc. common stock on the date of the deferral, or if no such price is reported for that date, the closing price for the next preceding date for which such price was reported. Each deferred stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock. The deferred stock units vest immediately upon grant and are payable only as common stock one year following the Director's resignation from the Board of Directors or on such other nondiscretionary and objectively determinable date(s) selected in accordance with the terms of the Plan.

SEC source: 0001246360-17-003180 · form.xml · nonDerivative · entry 19

Kingsley Lawrence D · CIK 0001301427 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,550.868

F1 · kind: The transactions reported in this Form 4 were executed by the reporting person's investment advisor in managed accounts as part of the investment advisor's implementation of large-cap investment strategies involving the securities of multiple issuers. The reporting person has voluntarily paid $7,213.77 to the issuer, representing the full amount of any short-swing profit that would be payable if the reported transactions were deemed subject to Section 16(b) of the Securities Exchange Act of 1934, as amended.

SEC source: 0001246360-17-003180 · form.xml · nonDerivative · entry 18

Kingsley Lawrence D · CIK 0001301427 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,602.868

F1 · kind: The transactions reported in this Form 4 were executed by the reporting person's investment advisor in managed accounts as part of the investment advisor's implementation of large-cap investment strategies involving the securities of multiple issuers. The reporting person has voluntarily paid $7,213.77 to the issuer, representing the full amount of any short-swing profit that would be payable if the reported transactions were deemed subject to Section 16(b) of the Securities Exchange Act of 1934, as amended.

SEC source: 0001209191-17-043787 · doc4.xml · derivative · entry 2

Kingsley Lawrence D · CIK 0001301427 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,978.07

Underlying: Common Stock · 259.97 shares

Expires not disclosed

F1 · security: Common Stock Equivalents (CSE) are credited to director accounts under the Company's Deferred Compensation Plan for Non-Employee Directors. The Plan has been approved by a vote of shareholders. Upon termination of his/her services, a Director is entitled to receive one share of common stock for each CSE earned.

F2 · derivative.exercise_price: 1 for 1 conversion

F1 · derivative.exercise_date: Common Stock Equivalents (CSE) are credited to director accounts under the Company's Deferred Compensation Plan for Non-Employee Directors. The Plan has been approved by a vote of shareholders. Upon termination of his/her services, a Director is entitled to receive one share of common stock for each CSE earned.

F1 · derivative.expiration_date: Common Stock Equivalents (CSE) are credited to director accounts under the Company's Deferred Compensation Plan for Non-Employee Directors. The Plan has been approved by a vote of shareholders. Upon termination of his/her services, a Director is entitled to receive one share of common stock for each CSE earned.

F3 · balance_after: Includes 11.35 CSEs acquired pursuant to a dividend reinvestment feature of the Plan.

SEC source: 0001140361-17-018659 · doc1.xml · derivative · entry 2

Kingsley Lawrence D · CIK 0001301427 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,046

Underlying: Common Stock · 3,046 shares

Expires 2027-05-02

F3 · price: Not applicable.

F2 · derivative.exercise_date: Grant of option to buy shares of IDEXX Laboratories, Inc. common stock that vest in one installment on May 3, 2018.

SEC source: 0001140361-17-018659 · doc1.xml · derivative · entry 1

Kingsley Lawrence D · CIK 0001301427 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 496

Underlying: Common Stock · 289 shares

Expires not disclosed

F1 · derivative.exercise_price: Each deferred stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock. Deferred stock units vest in one installment on the one year anniversary of the date of grant or on the date of the 2018 annual meeting of stockholders, whichever event is earlier, and are payable as common stock one year following the Director's resignation from the Board of Directors.

F3 · price: Not applicable.

F1 · derivative.exercise_date: Each deferred stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock. Deferred stock units vest in one installment on the one year anniversary of the date of grant or on the date of the 2018 annual meeting of stockholders, whichever event is earlier, and are payable as common stock one year following the Director's resignation from the Board of Directors.

F1 · derivative.expiration_date: Each deferred stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock. Deferred stock units vest in one installment on the one year anniversary of the date of grant or on the date of the 2018 annual meeting of stockholders, whichever event is earlier, and are payable as common stock one year following the Director's resignation from the Board of Directors.

SEC source: 0001140361-17-017678 · doc1.xml · nonDerivative · entry 1

Kingsley Lawrence D · CIK 0001301427 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,232

F1 · shares: Represents deferred stock units acquired pursuant to the IDEXX Laboratories, Inc. Director Deferred Compensation Plan (the "Plan") in accordance with Rule 16b-3. The number of deferred stock units, rounded up or down to the nearest whole unit, is determined by dividing the amount of cash compensation deferred pursuant to the Plan ($16,250.00) by the closing price of IDEXX Laboratories, Inc. common stock on the date of the deferral, or if no such price is reported for that date, the closing price for the next preceding date for which such price was reported. Each deferred stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock. The deferred stock units vest immediately upon grant and are payable only as common stock one year following the Director's resignation from the Board of Directors or on such other nondiscretionary and objectively determinable date(s) selected in accordance with the terms of the Plan.

SEC source: 0001209191-17-028949 · doc4.xml · derivative · entry 2

Kingsley Lawrence D · CIK 0001301427 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,860.99

Underlying: Common Stock · 1,505 shares

Expires not disclosed

F1 · security: The deferred stock units were granted under the Polaris Industries Inc. 2007 Omnibus Incentive Plan. The plan has been approved by a vote of shareholders. Upon termination of his/her services, a Director is entitled to receive one share of common stock for each deferred stock unit held.

F2 · derivative.exercise_price: 1 for 1 conversion

F1 · derivative.exercise_date: The deferred stock units were granted under the Polaris Industries Inc. 2007 Omnibus Incentive Plan. The plan has been approved by a vote of shareholders. Upon termination of his/her services, a Director is entitled to receive one share of common stock for each deferred stock unit held.

F1 · derivative.expiration_date: The deferred stock units were granted under the Polaris Industries Inc. 2007 Omnibus Incentive Plan. The plan has been approved by a vote of shareholders. Upon termination of his/her services, a Director is entitled to receive one share of common stock for each deferred stock unit held.

F3 · balance_after: Includes 36.99 deferred stock units acquired pursuant to dividend equivalent rights under the Plan.

SEC source: 0001209191-17-025800 · doc4.xml · derivative · entry 2

Kingsley Lawrence D · CIK 0001301427 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,706.75

Underlying: Common Stock · 293.32 shares

Expires not disclosed

F1 · security: Common Stock Equivalents (CSE) are credited to director accounts under the Company's Deferred Compensation Plan for Non-Employee Directors. The Plan has been approved by a vote of shareholders. Upon termination of his/her services, a Director is entitled to receive one share of common stock for each CSE earned.

F2 · derivative.exercise_price: 1 for 1 conversion

F1 · derivative.exercise_date: Common Stock Equivalents (CSE) are credited to director accounts under the Company's Deferred Compensation Plan for Non-Employee Directors. The Plan has been approved by a vote of shareholders. Upon termination of his/her services, a Director is entitled to receive one share of common stock for each CSE earned.

F1 · derivative.expiration_date: Common Stock Equivalents (CSE) are credited to director accounts under the Company's Deferred Compensation Plan for Non-Employee Directors. The Plan has been approved by a vote of shareholders. Upon termination of his/her services, a Director is entitled to receive one share of common stock for each CSE earned.

F3 · balance_after: Includes 9.08 CSEs acquired pursuant to a dividend reinvestment feature of the Plan.

SEC source: 0001246360-17-003180 · form.xml · nonDerivative · entry 17

Kingsley Lawrence D · CIK 0001301427 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,825.868

F1 · kind: The transactions reported in this Form 4 were executed by the reporting person's investment advisor in managed accounts as part of the investment advisor's implementation of large-cap investment strategies involving the securities of multiple issuers. The reporting person has voluntarily paid $7,213.77 to the issuer, representing the full amount of any short-swing profit that would be payable if the reported transactions were deemed subject to Section 16(b) of the Securities Exchange Act of 1934, as amended.

SEC source: 0001140361-17-010359 · doc1.xml · nonDerivative · entry 1

Kingsley Lawrence D · CIK 0001301427 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,135

SEC source: 0001246360-17-000487 · form.xml · nonDerivative · entry 1

Kingsley Lawrence D · CIK 0001301427 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,038.868

F1 · shares: Shares delivered as compensation for service as a director under the 2003 Directors Stock Plan.

SEC source: 0001140361-17-003779 · doc1.xml · nonDerivative · entry 1

Kingsley Lawrence D · CIK 0001301427 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 135

F1 · shares: Represents deferred stock units acquired pursuant to the IDEXX Laboratories, Inc. Director Deferred Compensation Plan (the "Plan") in accordance with Rule 16b-3. The number of deferred stock units, rounded up or down to the nearest whole unit, is determined by dividing the amount of cash compensation deferred pursuant to the Plan ($16,250.00) by the closing price of IDEXX Laboratories, Inc. common stock on the date of the deferral, or if no such price is reported for that date, the closing price for the next preceding date for which such price was reported. Each deferred stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock. The deferred stock units vest immediately upon grant and are payable only as common stock one year following the Director's resignation from the Board of Directors or on such other nondiscretionary and objectively determinable date(s) selected in accordance with the terms of the Plan.

SEC source: 0001246360-17-003180 · form.xml · nonDerivative · entry 16

Kingsley Lawrence D · CIK 0001301427 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,848.868

F1 · kind: The transactions reported in this Form 4 were executed by the reporting person's investment advisor in managed accounts as part of the investment advisor's implementation of large-cap investment strategies involving the securities of multiple issuers. The reporting person has voluntarily paid $7,213.77 to the issuer, representing the full amount of any short-swing profit that would be payable if the reported transactions were deemed subject to Section 16(b) of the Securities Exchange Act of 1934, as amended.

SEC source: 0001246360-17-003180 · form.xml · nonDerivative · entry 15

Kingsley Lawrence D · CIK 0001301427 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,019.868

F1 · kind: The transactions reported in this Form 4 were executed by the reporting person's investment advisor in managed accounts as part of the investment advisor's implementation of large-cap investment strategies involving the securities of multiple issuers. The reporting person has voluntarily paid $7,213.77 to the issuer, representing the full amount of any short-swing profit that would be payable if the reported transactions were deemed subject to Section 16(b) of the Securities Exchange Act of 1934, as amended.

SEC source: 0001209191-17-001694 · doc4.xml · derivative · entry 2

Kingsley Lawrence D · CIK 0001301427 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,404.35

Underlying: Common Stock · 295.06 shares

Expires not disclosed

F1 · security: Common Stock Equivalents (CSE) are credited to director accounts under the Company's Deferred Compensation Plan for Non-Employee Directors. The Plan has been approved by a vote of shareholders. Upon termination of his/her services, a Director is entitled to receive one share of common stock for each CSE earned.

F2 · derivative.exercise_price: 1 for 1 conversion

F1 · derivative.exercise_date: Common Stock Equivalents (CSE) are credited to director accounts under the Company's Deferred Compensation Plan for Non-Employee Directors. The Plan has been approved by a vote of shareholders. Upon termination of his/her services, a Director is entitled to receive one share of common stock for each CSE earned.

F1 · derivative.expiration_date: Common Stock Equivalents (CSE) are credited to director accounts under the Company's Deferred Compensation Plan for Non-Employee Directors. The Plan has been approved by a vote of shareholders. Upon termination of his/her services, a Director is entitled to receive one share of common stock for each CSE earned.

F3 · balance_after: Includes 7.42 CSEs acquired pursuant to a dividend reinvestment feature of the Plan.

SEC source: 0001209191-17-059648 · doc4.xml · nonDerivative · entry 4

Kingsley Lawrence D · CIK 0001301427 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,189.44

F2 · kind: The reporting person's purchase of Polaris common stock reported herein was matchable under Section 16(b) of the Securities Exchange Act of 1934 to the extent of 102 shares, with the reporting person's sale of shares of Polaris common stock at a price of $84.86 per share on November 21, 2016. The reporting person has paid the Company $551.92, representing the full amount of the profit realized in connection with the short-swing transaction.

F1 · balance_after: Reflects transactions occurring in a brokerage account managed by an investment advisor who maintained discretionary authority over the account. The reporting person's Form 4 reports filed between the dates of these transactions and the date of this report understated his total holdings by the corresponding amount of shares.

SEC source: 0001140361-16-088676 · doc1.xml · derivative · entry 2

Kingsley Lawrence D · CIK 0001301427 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,203

Underlying: Common Stock · 2,203 shares

Expires 2026-11-30

F1 · security: This equity grant represents pro rata equity compensation earned by the reporting person as a non-employee Director from his election to the IDEXX Laboratories, Inc. Board of Directors on October 19, 2016 until the 2017 annual meeting of stockholders.

F4 · price: Not applicable.

F3 · derivative.exercise_date: Grant of option to buy shares of IDEXX Laboratories, Inc. common stock that vests in one installment on May 3, 2017.

SEC source: 0001140361-16-088676 · doc1.xml · derivative · entry 1

Kingsley Lawrence D · CIK 0001301427 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 207

Underlying: Common Stock · 207 shares

Expires not disclosed

F1 · security: This equity grant represents pro rata equity compensation earned by the reporting person as a non-employee Director from his election to the IDEXX Laboratories, Inc. Board of Directors on October 19, 2016 until the 2017 annual meeting of stockholders.

F2 · derivative.exercise_price: Each deferred stock unit ("DSU") represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock. These DSUs will fully vest on the date of the 2017 annual meeting of stockholders or May 3, 2017, whichever event occurs earlier, and are payable as common stock one year following the Director's resignation from the Board of Directors.

F4 · price: Not applicable.

F2 · derivative.exercise_date: Each deferred stock unit ("DSU") represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock. These DSUs will fully vest on the date of the 2017 annual meeting of stockholders or May 3, 2017, whichever event occurs earlier, and are payable as common stock one year following the Director's resignation from the Board of Directors.

F2 · derivative.expiration_date: Each deferred stock unit ("DSU") represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock. These DSUs will fully vest on the date of the 2017 annual meeting of stockholders or May 3, 2017, whichever event occurs earlier, and are payable as common stock one year following the Director's resignation from the Board of Directors.

SEC source: 0001209191-17-059648 · doc4.xml · nonDerivative · entry 3

Kingsley Lawrence D · CIK 0001301427 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,039.44

F1 · balance_after: Reflects transactions occurring in a brokerage account managed by an investment advisor who maintained discretionary authority over the account. The reporting person's Form 4 reports filed between the dates of these transactions and the date of this report understated his total holdings by the corresponding amount of shares.

SEC source: 0001246360-16-006884 · form.xml · nonDerivative · entry 1

Kingsley Lawrence D · CIK 0001301427 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,770.868

F1 · shares: Shares delivered as compensation for service as a director under the 2003 Directors Stock Plan.

SEC source: 0001209191-16-145677 · doc4.xml · derivative · entry 2

Kingsley Lawrence D · CIK 0001301427 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,101.86

Underlying: Common Stock · 314.52 shares

Expires not disclosed

F1 · security: Common Stock Equivalents (CSE) are credited to director accounts under the Company's Deferred Compensation Plan for Non-Employee Directors. The Plan has been approved by a vote of shareholders. Upon termination of his/her services, a Director is entitled to receive one share of common stock for each CSE earned.

F2 · derivative.exercise_price: 1 for 1 conversion

F1 · derivative.exercise_date: Common Stock Equivalents (CSE) are credited to director accounts under the Company's Deferred Compensation Plan for Non-Employee Directors. The Plan has been approved by a vote of shareholders. Upon termination of his/her services, a Director is entitled to receive one share of common stock for each CSE earned.

F1 · derivative.expiration_date: Common Stock Equivalents (CSE) are credited to director accounts under the Company's Deferred Compensation Plan for Non-Employee Directors. The Plan has been approved by a vote of shareholders. Upon termination of his/her services, a Director is entitled to receive one share of common stock for each CSE earned.

F3 · balance_after: Includes 5.99 CSEs acquired pursuant to a dividend reinvestment feature of the Plan.

SEC source: 0001246360-17-003180 · form.xml · nonDerivative · entry 14

Kingsley Lawrence D · CIK 0001301427 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,416.868

F1 · kind: The transactions reported in this Form 4 were executed by the reporting person's investment advisor in managed accounts as part of the investment advisor's implementation of large-cap investment strategies involving the securities of multiple issuers. The reporting person has voluntarily paid $7,213.77 to the issuer, representing the full amount of any short-swing profit that would be payable if the reported transactions were deemed subject to Section 16(b) of the Securities Exchange Act of 1934, as amended.